Arbor Rapha Capital Bioholdings Corp. I

Arbor Rapha Capital Bioholdings Corp. I (Nasdaq: ARCK) is a blank-check company formed by sponsor Arbor Rapha Capital, a life-sciences-focused investment firm. The SPAC completed its initial public offering in 2021 and targeted acquisition opportunities in the biopharmaceutical and broader life-sciences sector. As of its 10-Q filing dated November 10, 2022, the company remained in its search phase, continuing to evaluate potential business-combination candidates within healthcare and biotechnology. The "Bioholdings" designation reflects the sponsor's explicit focus on biology-driven healthcare innovation. For comprehensive data on ARCK's deal timeline, SEC filings, and comparable SPAC metrics, sign up for full access at SpacDesk.